Skip to main content

Table 2 Comparison between the sepsis patients with and without thrombocytopenia

From: Platelet desialylation is a novel mechanism and a therapeutic target in thrombocytopenia during sepsis: an open-label, multicenter, randomized controlled trial

Variables

Sepsis without thrombocytopenia (n = 134)

Sepsis with thrombocytopenia (n = 127)

P value

 Age (year)

69.5 (54.5, 78.3)

68 (55.0, 77.0)

0.468

 Male

91 (67.9)

84 (66.1)

0.793

 APACHE II

18.5 (15.3, 23.8)

20 (10, 24.8)

0.861

  Predicted death rate (%)

31.5 (21, 45.2)

37.3 (20.4, 53.5)

0.217

 SOFA

5 (3.25, 7)

10 (5, 12)

<0.001

 PCT (ng/mL)

1.55 (0.32, 5.36)

6.69 (1.0, 38.9)

<0.001

 SA (mmol/L)

732.8 ± 156.5

669.1 ± 143.9

0.089

 MAP (mmHg)

86.8 ± 15.5

79.6 ± 14.7

<0.001

 Heart rate (beat/min)

93.3 (88.0, 106.3)

98 (84, 116)

0.221

 White blood cell (×109/L)

12.5 (8.4, 15.4)

14.1 (7.81, 15.5)

0.352

 Platelet count (×109/L)

196.5 (143.5, 299.75)

45 (33.25, 64.75)

<0.001

 BUN (mmol/L)

7.4 (5.18, 17.3)

7.51 (4.06, 14.6)

0.402

 Creatinine (μmol/L)

81 (56.0, 119.0)

88 (63.3, 225.0)

0.036

 Total bilirubin (μmol/L)

14.8 (9.9, 23.1)

18.8 (11.4, 35.0)

0.098

 Albumin (g/L)

25.5 ± 3.48

24.8 ± 5.75

0.267

Infection pathogens (%)

   Escherichia coli

12 (8.96)

25 (19.7)

0.020

   Klebsiella pneumoniae

22 (16.4)

11 (8.66)

0.065

   Pseudomonas aeruginosa

30 (22.4)

11 (8.66)

0.030

   Acinetobacter baumanii

13 (9.70)

7 (5.51)

0.248

   Staphylococcus aureus

21 (15.7)

5 (3.93)

0.020

   Streptococcus pneumonae

1 (0.75)

2 (1.57)

0.641

   Enterococcus faecium

5 (3.73)

4 (3.15)

0.999

 Chicken enterococcus

1 (0.75)

2 (1.57)

0.614

  Proteus mirabilis

0

1 (0.78)

0.487

  Candida albicans

1 (0.75)

2 (1.57)

0.614

  Aspergillus

3 (2.24)

7 (5.51)

0.207

 Viruses

17 (12.7)

36 (28.3)

0.002

  New Bunya virus

0

21 (16.5)

<0.001

  Influenza A virus subtype H1N1

6 (4.48)

6 (4.72)

0.999

  Others

11 (10.4)

9 (9.45)

0.818

Infection sites (%)

  Lung

69 (51.5)

29 (22.8)

<0.001

  Bloodstream

8 (5.97)

33 (23.6)

<0.001

  Abdominal cavity

11 (8.21)

15 (11.1)

0.409

  Hepatobiliary system

8 (5.97)

9 (6.9)

0.804

 Urinary system

6 (4.48)

8 (6.9)

0.589

 Surgical incision

3 (2.24)

3 (6.9)

0.632

 Skin and soft tissue

2 (1.49)

2 (1.4)

0.668

 Central nervous system

2 (1.49)

1 (1.4)

0.520

 Others

25 (18.7)

27 (21.3)

0.644

Platelet desialylation level (%)

 RCA-I

90.14 ± 8.88

95.64 ± 4.19

0.014

 ECL

2.33 ± 1.90

5.70 ± 4.37

<0.001

 sWGA

0.15 ± 0.95

0.50 ± 0.293

<0.001

 Mechanical ventilation

63 (47.0)

72 (56.7)

0.137

 Renal replacement therapy

19 (14.2)

32 (25.2)

0.029

 Septic shock

11 (8.2)

24 (18.9)

0.017

 ARDS

30 (22.4)

34 (26.8)

0.472

 Bleeding

32 (23.9)

29 (22.8)

0.884

 28-day mortality

19 (14.2)

46 (36.2)

<0.001

  1. Data are presented as number (percentage) or median (interquartile range); APACHE II acute physiology and chronic health evaluation scoring system, SOFA sequential organ failure assessment, PCT procalcitonin, ARDS acute respiratory distress syndrome, MAP mean arterial pressure, SA sialic acid, RCA-I Ricinus communis agglutinin I, ECL Erythrina cristagalli lectin, sWGA Succinyl Triticum vulgare lectin, BUN blood urea nitrogen